Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Receivables (2020 - 2025)

GoHealth's Receivables history spans 6 years, with the latest figure at $238.9 million for Q3 2025.

  • For Q3 2025, Receivables fell 13.81% year-over-year to $238.9 million; the TTM value through Sep 2025 reached $238.9 million, down 13.81%, while the annual FY2024 figure was $324.9 million, 64.38% down from the prior year.
  • Receivables for Q3 2025 was $238.9 million at GoHealth, up from $226.3 million in the prior quarter.
  • Across five years, Receivables topped out at $1.3 billion in Q4 2021 and bottomed at $130.4 million in Q2 2021.
  • The 5-year median for Receivables is $324.9 million (2024), against an average of $627.5 million.
  • The largest annual shift saw Receivables surged 7166.95% in 2021 before it crashed 74.76% in 2023.
  • A 5-year view of Receivables shows it stood at $1.3 billion in 2021, then fell by 19.04% to $1.0 billion in 2022, then fell by 11.99% to $911.9 million in 2023, then crashed by 64.38% to $324.9 million in 2024, then fell by 26.44% to $238.9 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Receivables are $238.9 million (Q3 2025), $226.3 million (Q2 2025), and $213.3 million (Q1 2025).